4.8 Article

Patched 1 regulates Smoothened by controlling sterol binding to its extracellular cysteine-rich domain

期刊

SCIENCE ADVANCES
卷 8, 期 22, 页码 -

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.abm5563

关键词

-

资金

  1. Cancer Research UK [C20724/A26752]
  2. European Research Council [647278]
  3. National Institutes of Health [GM118082, GM106078]
  4. NIH [HL067773]
  5. Wellcome [208361/Z/17/Z]
  6. BBSRC [BB/R00126X/1]
  7. National Science Foundation
  8. Wellcome Trust [203726/Z/16/Z, 102164/Z/13/Z]
  9. Ford Foundation
  10. Wellcome Trust Core Award [203141/Z/16/Z]
  11. Wellcome Trust [203726/Z/16/Z] Funding Source: Wellcome Trust

向作者/读者索取更多资源

This study reveals that cholesterol plays different roles in the two binding sites of SMO. Cholesterol acts as a regulated orthosteric ligand at the CRD site and an allosteric ligand at the TMD site, regulating the activity of SMO and Hh signaling.
Smoothened (SMO) transduces the Hedgehog (Hh) signal across the plasma membrane in response to accessible cholesterol. Cholesterol binds SMO at two sites: one in the extracellular cysteine-rich domain (CRD) and a second in the transmembrane domain (TMD). How these two sterol-binding sites mediate SMO activation in response to the ligand Sonic Hedgehog (SHH) remains unknown. We find that mutations in the CRD (but not the TMD) reduce the fold increase in SMO activity triggered by SHH. SHH also promotes the photocrosslinking of a sterol analog to the CRD in intact cells. In contrast, sterol binding to the TMD site boosts SMO activity regardless of SHH exposure. Mutational and computational analyses show that these sites are in allosteric communication despite being 45 angstroms apart. Hence, sterols function as both SHH-regulated orthosteric ligands at the CRD and allosteric ligands at the TMD to regulate SMO activity and Hh signaling.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据